UNSPSC 51401531: Nordazepam

This classification denotes a benzodiazepine with the molecular formula C15H11ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67220MCM01, chemically known as 7-chloro-5-phenyl-1,3-dihydro-2h-1,4-benzodiazepin-2-one but generally known as nordazepam, which bears US NIH Compound Identifier 2997. European Medicines Agency schedules Nordazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09358MIG.

UNSPSC 51401531 Nordazepam, a Commodity code, does not align with state and local procurement activity currently tagged under it. The single recent opportunity on record — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and drug deactivation systems for community health initiatives, not nordazepam or other benzodiazepines. The mismatch suggests either a classification error in the source data or that the code is not actively used for its nominal scope in state and local procurement. Nordazepam, a synthetic benzodiazepine, would typically appear in pharmaceutical or controlled-substance procurement for public health or correctional agencies, but no such opportunities are visible in the recent-opportunities block.

Seminole County's naloxone and drug deactivation system procurement (posted June 30, 2026, with response due July 26, 2026) represents the only documented recent activity under this code. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems on an annual basis through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with an initial two-year term and one-year renewal option. Vendors must comply with E-Verify, workers' compensation and liability insurance, drug-free workplace certification, and potential FEMA compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. The contract was structured on a fixed-fee basis with a three-month probationary termination clause.